-
Mashup Score: 0
AbstractBackground. Guidelines recommend extended dual antiplatelet therapy (DAPT), including ticagrelor 60 mg twice daily, in high-risk post myocardial infarct
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis - 2 year(s) ago
AbstractAims. To summarise the totality of evidence validating the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Du
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
External validity of PRECISE-DAPT score in patients undergoing #PCI: a meta-analysis of 21 studies and >67K patients 🩸 https://t.co/aBSvNLfw2Q @Costa_F_8 @vlgmrc @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/Wf2Huct7K7
-
-
Mashup Score: 1Most Read Articles - 2 year(s) ago
See what your peers are reading! The European Heart Journal – Cardiovascular Pharmacotherapy editors invite you to read the top 20 most read articles published
Source: academic.oup.comCategories: General Medicine News, Latest HeadlinesTweet-
Making the most of #ESCCongress 2023 day 4 by attending the #EHJPharmacotherapy editorial board meeting, led by @AgewallStefan. Take a look at the Journal’s most popular recently published articles ➡️ https://t.co/aCbmZ5OBA8 https://t.co/gan9uWQFG1
-
-
Mashup Score: 0Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition - 2 year(s) ago
AbstractAims. Platelet activation and endothelial dysfunction contribute to adverse outcomes in patients with acute coronary syndromes (ACS). The goals of this
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
PCSK9-I to reduce platelet activation and endothelial dysfunction in the early post-infarction period: a biomarker study 🔥 https://t.co/s3PotZupc6 @TZiogos @TLeucker @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/2eFlcbO3Fz
-
-
Mashup Score: 27The Effect of SGLT2 Inhibitors on the Endothelium and the Microcirculation: From Bench to Bedside and Beyond - 2 year(s) ago
Abstract. The beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors irrespective of the presence of diabetes mellitus are nowad
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Evidence suggests a beneficial effect of #SGLT2i on endothelial function, but their effect on microcirculation is conflicting: a new review article by @KyriakosDimitr1 et al. covers this evolving area https://t.co/97u28m4phW @AgewallStefan @FeliceGragnano #EHJPharmacotherapy… https://t.co/NXGiMGJQY3 https://t.co/tMmwO7n494
-
-
Mashup Score: 0Cardiovascular events in patients treated with bempedoic acid versus placebo: systematic review and meta-analysis - 2 year(s) ago
AbstractAims. Reduction of low-density lipoprotein cholesterol (LDL-C) decreases cardiovascular mortality and morbidity. Bempedoic acid represents a promising n
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Bempedoic acid for the prevention of cardiovascular events in patients with an indication for lipid-lowering therapy: a meta-analysis of 10 randomised trials https://t.co/PswEP3vj0K @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/0eYyBBWrDn
-
-
Mashup Score: 8
AbstractAims. To characterize and follow patients with ST-segment elevation myocardial infarction (STEMI) at high bleeding risk (HBR) according to the predictin
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
P2Y12 inhibitor type and subsequent risk of CV events and bleeding in #STEMI patients at #HBR: a Danish 🇩🇰 all-comer registry https://t.co/MKteMIepVV @AgewallStefan @FeliceGragnano #PCI #DAPT #ESCYoung #EHJPharmacotherapy https://t.co/mnDkUs4FiM
-
-
Mashup Score: 0
AbstractAims. We studied the effect of discontinuing beta-blockers following myocardial infarction in comparison to continuous beta-blocker use in optimally tre
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In a 🇩🇰 study of >21K pts with MI without HF, B-blockers discontinuation was not associated with worse outcomes, but signals of excess risk of CV events were found with early discontinuation (<2 years) https://t.co/OWSeMXxh63 @AgewallStefan @FeliceGragnano #EHJPharmacotherapy https://t.co/Ac1i9YyJV0
-
-
Mashup Score: 3
There have been major advances in cardiovascular pharmacotherapy in recent decades, but many evidence gaps remain. Our patients have high expectations of cardio
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The year in cardiovascular #pharmacotherapy 2022: Landmark evidence at a glance 💊 https://t.co/NucEKB587g @AgewallStefan @FeliceGragnano @paolocalabro1 @v_desio #EHJPharmacotherapy #ESCYoung #HeartFailure #Diabetes #Lipids #Obesity #FXIa #RareDisease https://t.co/nz3BMpd5Sr
-
-
Mashup Score: 2Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants - 2 year(s) ago
AbstractAims. Atrial fibrillation (AF) is linked to an increased risk of dementia, even in stroke-free patients. The impact of statin therapy on dementia risk i
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In patients with #AFib, statin therapy was associated with a lower risk of dementia 🧠 with a dose-dependent effect: a nationwide Korean study https://t.co/M5qzfcsNZE @AgewallStefan @FeliceGragnano @escardio #EHJPharmacotherapy #ESCYoung #AF #statins https://t.co/RIqHjxyAIi
-
Clinical outcomes in patients with prior #MI treated with extended #DAPT with #ticagrelor 60 mg: data from the multinational ALETHEIA study https://t.co/Vlx2TxIwsZ @MarcBonaca @AgewallStefan @FeliceGragnano #EHJPharmacotherapy https://t.co/4TLQl6tEab